Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06843213 · ClinicalTrials.gov registry record · NA

Teaching Health Resilience in a Hospital Setting: A Peer-led Intervention

A NA study of Opioid Use Disorder and Health Promotion, sponsored by University of Pennsylvania.

Recruiting
Registry status
NA
Development phase
390
Enrollment target
3
Study locations

NCT06843213: Recruiting NA study of Opioid Use Disorder and Health Promotion, sponsored by University of Pennsylvania.

NCT06843213 is a NA study of Opioid Use Disorder and Health Promotion that is actively recruiting participants, run by University of Pennsylvania. The registered enrollment target is 390 participants, below the 4,655-participant average among 257 other Opioid Use Disorder trials with a reported enrollment target (92% lower). The trial reports 3 study locations across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06843213, a NA study of Opioid Use Disorder and Health Promotion, is actively recruiting participants, sponsored by University of Pennsylvania.

RECRUITING
Registry status
NA
Development phase
390 participants
Enrollment target
3
Study locations

Study Summary

The purpose of the study is to develop an acceptable, feasible, and effective peer-led bundle of health resilience and promotion services to be delivered in the hospital setting, called the THRIVE intervention. The main question it aims to answer is: Will participants receiving the THRIVE intervention have a reduced risk of self-reported non-fatal overdoses OR skin/soft tissue infections compared to participants receiving enhanced usual care? Researchers will compare the THRIVE model to enhanced usual care to see if the THRIVE model helps participants reduce their number of self-reported non-fatal overdoses OR skin/soft tissue infections. Intervention participants will: * Receive one in-person session from a peer support specialist while in the hospital * Receive weekly text messages from the peer support specialist for a 12-week period * Receive monthly, multiple-choice assessments via text message at Month 1, 2, 3, 4, 5, and 6 * Complete a baseline, 3-month, and 6-month assessment with Research Assistants Enhanced usual care participants will: * Receive a handout with health resilience education and resources in their local area * Receive monthly, multiple-choice assessments via text message at Month 1, 2, 3, 4, 5, and 6 * Complete a baseline, 3-month, and 6-month assessment with Research Assistants

Primary Outcome

Cumulative incidence of non-fatal overdose OR skin and soft tissue infection

Interventions

  • BEHAVIORAL Peer Intervention
  • OTHER Enhanced Usual Care

Study Locations (3)

Pennsylvania

  • UPMC Mercy Hospital - Pittsburgh
  • UPMC Presbyterian-Montefiore Hospital - Pittsburgh
  • UPMC Shadyside Hospital - Pittsburgh

Trial Details

FieldValue
Enrollment Target 390 participants
Start Date 2025-02-18
Est. Completion 2028-08-01
Phase NA
University of Pennsylvania

1,423 total trials

What NCT06843213 shows while recruiting

NCT06843213 is an interventional study that assigns participants to a tested intervention. The registered 390 participants enrollment target is mid-sized for trials with a published cap, below the 4,655-participant average among 257 other Opioid Use Disorder trials with a reported enrollment target (92% lower).

The record links to 3 conditions, with Opioid Use Disorder appearing as the primary indexed condition, and to 2 interventions - of which Peer Intervention is the first listed.

NCT06843213 reports a single indexed study location in Pennsylvania.

Frequently Asked Questions

What is clinical trial NCT06843213 about?

NCT06843213 is a clinical study titled "Teaching Health Resilience in a Hospital Setting: A Peer-led Intervention". The purpose of the study is to develop an acceptable, feasible, and effective peer-led bundle of health resilience and promotion services to be delivered in the hospital setting, called the THRIVE intervention. The main question it aims to answer is: Will participants receiving the THRIVE intervent...

What is the current status of trial NCT06843213?

This trial is currently recruiting. It is a NA study. The enrollment target is 390 participants. The study started on 2025-02-18. Estimated completion is 2028-08-01.

What conditions does trial NCT06843213 study?

This clinical trial studies the following conditions: Opioid Use Disorder, Health Promotion, Harm Reduction.

What interventions are being tested in trial NCT06843213?

The interventions under investigation include: Peer Intervention (BEHAVIORAL), Enhanced Usual Care (OTHER).

Who is sponsoring clinical trial NCT06843213?

This trial is sponsored by University of Pennsylvania, which has 1,423 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06843213 being conducted?

This trial has 3 study locations across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Opioid Use Disorder

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT06843213's enrollment target sits among peer trials

390 47th of 257 higher than 211 of 257 other Opioid Use Disorder trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Opioid Use Disorder trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00397111 · 390 participants

    Development of Magnetic Resonance Imaging Techniques for Studying Mood and Anxiety Disorders

  • NCT05335928 · 390 participants · Phase 3

    Abatacept in Immune Checkpoint Inhibitor Myocarditis

  • NCT05445960 · 390 participants · NA

    Correlation Between Intraoperative Tourniquet Use and Limb pH, Functional Measures and Patient-reported Outcomes After Ankle Fracture Surgery

  • NCT05997615 · 390 participants · Phase 1

    Safety, Pharmacokinetics, and Preliminary Efficacy of VIR-5500 (AMX-500) in Prostate Cancer

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT06843213, the US trial registry maintained by the National Library of Medicine. NCT06843213 (mid enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.